David B. Roberts - Dec 11, 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: President and Director, Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol: LMAT
Transactions as of: Dec 11, 2022
Transactions value $: -$8,913
Form type: 4
Date filed: 12/13/2022, 04:21 PM
Previous filing: Dec 6, 2022
Next filing: Dec 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Options Exercise	$0	+4	+0.03%	$0.00	14.7K	Dec 11, 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	-$8.91K	-192	-1.31%	$46.42	14.5K	Dec 11, 2022	Direct	F2
transaction	LMAT	Common Stock	Award	$0	+2.65K	+18.32%	$0.00	17.1K	Dec 12, 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-4	-14.91%	$0.00	22.8	Dec 11, 2022	Common Stock	4		Direct	F4
transaction	LMAT	Stock Option (Right to Buy)	Award	$0	+13.7K		$0.00	13.7K	Dec 12, 2022	Common Stock	13.7K	$47.19	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3	Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F4	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5	This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.